|Day's range||534.10 - 546.50|
|52-week range||492.65 - 854.95|
|PE ratio (TTM)||18.51|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|
Mumbai, June 13 (IANS) Drug major Sun Pharmaceutical Industries on Tuesday announced that one of its wholly owned subsidiaries has received final approval from the US Food and Drug Administration (USFDA) ...
Dilip Shanghvi’s shrinking fortune has become one of the most visible casualties of the troubles hitting India’s generic drug industry. Once India’s richest person, he recently slipped to No. 6 with his ...
By Krishna V Kurup REUTERS - India's benchmark BSE Sensex edged higher to a record close for a third consecutive session as consumer goods stocks gained, but broader advances were capped by falls in companies ...